NCT04919512 · Interventional trial
A Study of TAR-200 in Combination With Cetrelimab and Cetrelimab Alone in Participants With Muscle-Invasive Urothelial Carcinoma of the Bladder
Overall registry status Completed
Phase 2
Conditions Urinary Bladder Neoplasms
Delaware Valley sites
- MidLantic Urology · Bala-Cynwyd, PA · Montgomery County
First posted
Registry updated
Added to the directory